Edmond DE Rothschild Holding S.A. Makes New $169.90 Million Investment in Bruker Corporation $BRKR

Edmond DE Rothschild Holding S.A. bought a new position in shares of Bruker Corporation (NASDAQ:BRKR) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 2,823,178 shares of the medical research company’s stock, valued at approximately $169,899,000. Bruker makes up 2.2% of Edmond DE Rothschild Holding S.A.’s investment portfolio, making the stock its 8th biggest holding.

A number of other institutional investors and hedge funds also recently modified their holdings of BRKR. Orbis Allan Gray Ltd raised its position in shares of Bruker by 5.4% in the 4th quarter. Orbis Allan Gray Ltd now owns 14,906,730 shares of the medical research company’s stock valued at $702,256,000 after acquiring an additional 761,258 shares during the period. Pallas Capital Advisors LLC acquired a new position in Bruker during the second quarter valued at approximately $570,746,000. State Street Corp grew its holdings in Bruker by 2.5% during the fourth quarter. State Street Corp now owns 3,831,814 shares of the medical research company’s stock valued at $180,700,000 after purchasing an additional 91,706 shares during the period. AQR Capital Management LLC increased its stake in Bruker by 125.3% in the second quarter. AQR Capital Management LLC now owns 3,326,820 shares of the medical research company’s stock valued at $137,065,000 after purchasing an additional 1,850,215 shares in the last quarter. Finally, Sculptor Capital LP raised its holdings in Bruker by 9.0% in the first quarter. Sculptor Capital LP now owns 3,270,000 shares of the medical research company’s stock worth $118,112,000 after purchasing an additional 270,000 shares during the period. 79.52% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on BRKR. JPMorgan Chase & Co. lifted their price target on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research report on Monday, June 8th. TD Cowen reaffirmed a “hold” rating on shares of Bruker in a research note on Wednesday, July 15th. Leerink Partners lifted their target price on Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a report on Tuesday, July 7th. Weiss Ratings raised Bruker from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Finally, Wall Street Zen upgraded Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $56.64.

Bruker Stock Up 3.1%

Bruker stock opened at $58.65 on Thursday. The stock has a market capitalization of $8.94 billion, a PE ratio of -83.79, a price-to-earnings-growth ratio of 1.74 and a beta of 1.28. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $65.30. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76. The company has a 50 day moving average of $58.46 and a 200-day moving average of $47.28.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.11. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The company had revenue of $838.50 million during the quarter, compared to the consensus estimate of $853.57 million. During the same quarter in the prior year, the firm earned $0.32 earnings per share. The firm’s revenue was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, equities research analysts anticipate that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Monday, September 21st. Bruker’s dividend payout ratio is -28.57%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.